LEXICON PHARMACEUTICALS, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Lexicon Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Lexicon Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$55.4M, a 25.1% decline year-over-year.
  • Lexicon Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$197M, a 53% decline year-over-year.
  • Lexicon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$172M, a 70.5% decline from 2022.
  • Lexicon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$101M, a 15.7% decline from 2021.
  • Lexicon Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$87.1M, a 82.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$197M -$55.4M -$11.1M -25.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 -$186M -$45.3M -$14.2M -45.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$172M -$46.7M -$16.5M -54.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$155M -$49.6M -$26.5M -115% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 -$129M -$44.2M -$20.2M -84.3% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 -$109M -$31.1M -$7.76M -33.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 -$101M -$30.3M -$4.95M -19.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$95.8M -$23.1M -$133K -0.58% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$95.7M -$24M -$6.05M -33.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$89.6M -$23.4M -$2.54M -12.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$87.1M -$25.3M -$17.9M -240% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-25
Q3 2021 -$69.2M -$23M -$110M -126% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $40.4M -$18M +$46.6M +72.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 -$6.2M -$20.8M +$41.6M +66.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$47.8M -$7.46M +$39.8M +84.2% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-03
Q3 2020 -$87.6M $86.7M -$138M -61.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $50.4M -$64.6M -$46M -248% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $96.5M -$62.4M -$45M -257% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $141M -$47.2M -$34.9M -282% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-12
Q3 2019 $176M $225M +$248M Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 -$71.3M -$18.5M +$11.7M +38.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 -$83M -$17.5M +$20.2M +53.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-04-27
Q4 2018 -$103M -$12.4M +$16.6M +57.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$120M -$22.9M +$5.68M +19.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-12
Q2 2018 -$126M -$30.3M +$3.22M +9.61% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-12
Q1 2018 -$129M -$37.7M +$1.8M +4.55% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-12
Q4 2017 -$131M -$29M +$2.31M +7.39% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 -$133M -$28.6M +$6.33M +18.1% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-15
Q2 2017 -$139M -$33.5M +$3.53M +9.54% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-15
Q1 2017 -$143M -$39.5M -$5.64M -16.7% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-15
Q4 2016 -$137M -$31.3M -$120M -135% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$17.5M -$34.9M -$1.26M -3.73% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$16.2M -$37M -$10.3M -38.7% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$5.88M -$33.9M -$7.34M -27.7% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 $1.47M $88.4M +$91.8M Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 -$90.3M -$33.7M +$6.66M +16.5% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 -$97M -$26.7M -$577K -2.21% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 -$96.4M -$26.5M +$3.95M +12.9% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 -$100M -$3.45M +$13.5M +79.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$114M -$40.3M -$9.12M -29.2% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-11
Q2 2014 -$105M -$26.1M +$2.51M +8.78% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-11
Q1 2014 -$107M -$30.5M -$4.92M -19.2% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-11
Q4 2013 -$102M -$17M +$7.52M +30.7% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-12
Q3 2013 -$110M -$31.2M -$2.16M -7.42% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-12
Q2 2013 -$108M -$28.6M -$3.14M -12.3% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-12
Q1 2013 -$105M -$25.6M +$3.83M +13% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-12
Q4 2012 -$108M -$24.5M +$8.85M +26.5% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-07
Q3 2012 -$117M -$29.1M -$3.37M -13.1% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-07
Q2 2012 -$114M -$25.5M +$446K +1.72% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-07
Q1 2012 -$114M -$29.4M -$247K -0.85% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-07
Q4 2011 -$114M -$33.3M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-11
Q3 2011 -$25.7M -$1.44M -5.93% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-11
Q2 2011 -$25.9M -$1.85M -7.69% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-11
Q1 2011 -$29.1M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-11
Q3 2010 -$24.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-01
Q2 2010 -$24.1M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.